It was also interesting to note that AHNAK mutated GBMs, who have poor survival, were enriched in poor prognostic groups as identified by G-CIMP, IDH1, MGMT promoter methylation and also in mesenchymal subtype of GBM. This evidence concerns the gene IDH1 and glioblastoma.